Vivus President on Qnexa Obesity Drug
Feb. 23 (Bloomberg) -- Peter Tam, president of Vivus Inc., talks about the outlook for the company's Qnexa obesity drug after U.S. Food and Drug Administration advisers voted 20-2 yesterday that the pill's benefits outweigh its risks.
Tam speaks with Bloomberg's Shannon Pettypiece. (Excerpts. Source: Bloomberg)